These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Triptans in migraine--here and now (15 years after they were implemented in therapy)]. Prusiński A; Rozniecki JJ Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574 [TBL] [Abstract][Full Text] [Related]
27. Function of the peripheral serotoninergic pathways in migraine: a proposal for an experimental model. Martelletti P; Stirparo G; Rinaldi C; Fusco BM Cephalalgia; 1994 Feb; 14(1):11-5; discussion 4. PubMed ID: 7515328 [TBL] [Abstract][Full Text] [Related]
28. Serotonin receptors and the acute attack of migraine. Goadsby PJ Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053 [TBL] [Abstract][Full Text] [Related]
29. Sumatriptan. An updated review of its use in migraine. Perry CM; Markham A Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601 [TBL] [Abstract][Full Text] [Related]
30. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew. Goldstein D Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072 [No Abstract] [Full Text] [Related]
31. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists. Ferrari MD Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266 [TBL] [Abstract][Full Text] [Related]
32. Molecule of the month. Lasmiditan hydrochloride. Drug News Perspect; 2010 Sep; 23(7):455. PubMed ID: 20862397 [No Abstract] [Full Text] [Related]
33. Re: Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia 2001;21:727-32. Ferrari MD Cephalalgia; 2001 Sep; 21(7):711. PubMed ID: 11603382 [No Abstract] [Full Text] [Related]
34. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Goadsby PJ; Hargreaves RJ Neurology; 2000; 55(9 Suppl 2):S8-14. PubMed ID: 11089513 [TBL] [Abstract][Full Text] [Related]
35. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Deleu D; Hanssens Y Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351 [TBL] [Abstract][Full Text] [Related]
36. Review of zolmitriptan and its clinical applications in migraine. Dowson AJ; Charlesworth B Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998 [TBL] [Abstract][Full Text] [Related]
37. Possible role of alpha-adrenoceptor subtypes in acute migraine therapy. Willems EW; Valdivia LF; Villalón CM; Saxena PR Cephalalgia; 2003 May; 23(4):245-57. PubMed ID: 12716341 [TBL] [Abstract][Full Text] [Related]
38. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs]. Amelin AV; Skoromets AA; Ignatov IuD Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805 [No Abstract] [Full Text] [Related]
39. Migraine and its treatment with 5-HT1B/1D agonists (triptans). Moriarty-Sheehan M J Am Acad Nurse Pract; 2002 Aug; 14(8):354-9; quiz 360-2. PubMed ID: 12242852 [TBL] [Abstract][Full Text] [Related]
40. Advances in understanding the pathophysiology of headache. Silberstein SD Neurology; 1992 Mar; 42(3 Suppl 2):6-10. PubMed ID: 1557193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]